RNDr. Bc. Iveta Selingerová, Ph.D.
Assistant professor, Department of Mathematics and Statistics
Office: pav. 08/03016b
Kotlářská 267/2
611 37 Brno
Phone: | +420 549 49 5454 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 69
2024
-
Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice
Reports of Practical Oncology and Radiotherapy, year: 2024, volume: 29, edition: 1, DOI
-
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice
Frontiers in Medicine, year: 2024, volume: 10, DOI
-
Hippocampal subfield volumetric changes after radiotherapy for brain metastases
NEURO-ONCOLOGY ADVANCES, year: 2024, volume: 6, edition: 1, DOI
-
Challenges with hippocampal MR spectroscopy as a surrogate for pre-radiotherapy assessment of neurocognitive impairment in patients with brain metastasis
Biomedical Papers, Olomouc: Palacky University, year: 2024, DOI
-
Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study
Radiation Oncology, year: 2024, volume: 19, edition: 1, DOI
-
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic
Oncologist, year: 2024, DOI
2023
-
AGR2 and TGF-β associated changes in transcriptome and proteome of cancer cell lines
Year: 2023, type: Conference abstract
-
Analýza VEGF -D v séru pacientek s benigními a maligními adnextumory - potenciální přínos pro diferenciální diagnostiku, predikci a screening
Year: 2023, type: Conference abstract
-
Comparison of 3 Different Systems for Non-wire Localization of Lesions in Breast Cancer Surgery
Clinical Breast Cancer, year: 2023, volume: 23, edition: 6, DOI
-
CoVigi phase IV multicentric trial evaluating COVID-19 vaccination effectiveness, safety, and immune response dynamics: SARS-CoV-2-specific antibody and T-cell response focused on patients with gastrointestinal tumors
Year: 2023, type: Conference abstract